Jérôme Lemoine (M) is Professor at Lyon 1 University, head of the bioMolecular Mass Spectrometry team in the Institut des Sciences Analytiques. He moved to Lyon in 2004 with the objective of developing a multidisciplinary team in the field of biological mass spectrometry. Since then, his research topics have been focused on interdisciplinary mass spectrometry developments to improve the structural and quantitative analysis of biomolecules in the context of human diseases such as Alzheimer, cancer or high blood pressure.
He has been involved in the supervision or co-supervision of 15 PhD sudents.
Jérôme Lemoine has published 98 papers (H factor 30), filled 3 patents, and is co-founder of the start-up company AnaQuant.

Research
Methodological and instrumental developments in mass spectrometry and hyphenated techniques for the relative or absolute multiplexed quantification of proteins in biological matrices : from proteomic discovery to clinical applications
improved detection specificity by coupling laser photodissociation to mass spectrometry or MRM3
increased multiplexing capability

Keywords
targeted mass spectrometry, laser photodissociation, ion mobility, protein/peptide biomarkers, clinical studies